Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 10, 2026
TickeronGET DAILY SIGNALS
GROV Stock: Exploring the Path to +82% Upside Toward the $2 Target

GROV Stock: Exploring the Path to +82% Upside Toward the $2 Target

Key Takeaways

  • The $2.00 central target comes from public discussion, specifically the single published analyst price target for Grove Collaborative Holdings, Inc. (GROV), a NYSE-listed sustainable consumer products company, rather than a broad multi-analyst consensus.
  • With the stock recently trading near $1.10, reaching $2.00 would require roughly 82% upside, a substantial move for any company.
  • Coverage remains extremely thin, with essentially one analyst (Canaccord Genuity) setting a $2.00 target and Buy rating, leaving no meaningful low-to-high target range to average.
  • Supporting factors include three consecutive quarters of positive adjusted EBITDA, narrowing losses, insider buying, and a sustainability-focused brand position.
  • Principal risks include declining revenue, continued net losses, a NYSE continued-listing notice, and very low trading liquidity typical of a micro-cap.
  • For additional detail, explore the company's Major News, Today's Price Move, Forecast, and Earnings pages.
  • Readers can also monitor Trending AI Robots to see how automated strategies are positioning across the market.

Analyst Price Targets and Consensus View

In my view, GROV lacks a meaningful analyst consensus. Publicly available data shows effectively a single active sell-side voice: Canaccord Genuity analyst Susan Anderson, who maintains a Buy rating with a $2.00 price target. That target was raised from $1.50 in November 2025 and reiterated through 2026. Because this is one analyst's published objective rather than an average of multiple independent forecasts, the $2.00 figure is treated here as a publicly discussed price objective, not an "average analyst price target."

This concentration matters. A single target can swing sharply on one report, and Anderson's own history with GROV shows the volatility—the target was cut from $3.00 to $2.00 in August 2025 before the later revision. The $2.00 level reflects Canaccord's view that improving profitability and e-commerce stabilization can support a re-rating, but it is a single, high-uncertainty data point rather than a broad Street endorsement. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

GROV recently traded around $1.10, giving the company a market capitalization of roughly $47 million and a 52-week range of about $0.86 to $1.55. Reaching $2.00 would require approximately 82% appreciation—a very large move, particularly for a company still reporting losses on a generally accepted accounting principles (GAAP) basis, with negative EPS (earnings per share) of about $0.20 over the trailing twelve months and a price-to-sales ratio near 0.27.

The path would have to run through continued margin improvement and a return to revenue growth. Management has guided 2026 net revenue to approximately $140–$150 million, down from $173.7 million in 2025, while targeting breakeven adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization). A move toward $2.00 likely hinges on investors beginning to price a durable return to growth rather than simply cost discipline.

What Could Support a Move Toward the Target

  • Profitability inflection: The company has posted three consecutive quarters of positive adjusted EBITDA, and full-year losses narrowed by roughly half between 2024 and 2025.
  • Cost discipline: Management has trimmed advertising spend and focused on customer experience, lifting gross margins and loyalty adoption.
  • Brand differentiation: GROV's plastic-reduction and human-health positioning gives it a niche in the consumer packaged goods market.
  • Insider confidence: CEO Jeffrey Yurcisin has been a consistent open-market buyer, a signal some investors read as management conviction.
  • Low valuation base: At about 0.27 times trailing sales, the stock has substantial room to re-rate if fundamentals stabilize.

What Could Prevent the Target From Being Reached

  • Shrinking revenue: Sales declined about 15% in 2025 and are guided lower again in 2026, raising questions about whether growth can resume.
  • Persistent losses: The company remains unprofitable on a GAAP basis, and breakeven adjusted EBITDA is only an intermediate milestone.
  • Exchange listing risk: In August 2026, GROV disclosed a NYSE notice of non-compliance under the exchange's continued-listing standards, a meaningful overhang.
  • Micro-cap liquidity: With a market cap near $47 million and thin average volume, the stock can be volatile and difficult to trade in size.
  • Concentration of opinion: A single analyst target provides no independent confirmation and can shift quickly with one revision.

Technical Levels and Market Structure

The $2.00 target sits well above the stock's recent 52-week high near $1.55. That $1.55 area represents a notable prior ceiling, while the $0.86 low marks durable support on the downside. Because GROV is a low-float micro-cap with modest volume, technical levels are best treated as loose zones rather than precise resistance. A sustained move toward $2.00 would first require clearing the mid-$1.50 area, a level the stock has not decisively held above in the past year.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a research horizon of roughly 12 months, though a single-target situation carries less precision about timing. Upcoming items most relevant to the $2.00 objective include quarterly earnings and guidance, particularly any sign that revenue declines are bottoming and that adjusted EBITDA remains positive; further analyst revisions (or the emergence of additional coverage); and resolution of the NYSE continued-listing notice. Macroeconomic factors such as consumer spending trends and interest rates also matter, since discretionary e-commerce demand is sensitive to household budgets.

Using AI Daily Buy/Sell Signals in Research

For traders seeking a data-driven complement to fundamental research, AI Daily Buy/Sell Signals uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than replacing due diligence, the tool is designed to help investors discover opportunities, monitor existing positions, and spot shifting trends more efficiently across a broad universe of securities. Traders interested in automating part of their market screening may find the signals a useful addition to their workflow. From what I see, integrating these signals has helped me cross-check timing on names like GROV without replacing core analysis.

Final Assessment

Can GROV reach $2? The target is real but fragile: it reflects a single Canaccord Genuity objective of $2.00, not a broad analyst consensus, and it sits roughly 82% above the recent price near $1.10—a very large required move. The bull case rests on a genuine profitability inflection, narrowing losses, insider buying, and a low valuation base; the bear case rests on shrinking revenue, ongoing GAAP losses, a NYSE listing notice, and thin liquidity. Because the target rests on one voice, investors should weight the company's actual operating trajectory—revenue stabilization and sustained positive EBITDA—more heavily than the headline price forecast itself. One thing that stands out is how closely the stock's path tracks these operational milestones.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GROV

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


GROV in upward trend: price rose above 50-day moving average on October 23, 2026

GROV moved above its 50-day moving average on October 23, 2026 date and that indicates a change from a downward trend to an upward trend. In 47 of 60 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on GROV as a result. In 76 of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for GROV just turned positive on October 23, 2026. Looking at past instances where GROV's MACD turned positive, the stock continued to rise in 32 of 43 cases over the following month. The odds of a continued upward trend are 74%.

The 10-day moving average for GROV crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 19 of 25 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.

Following a +4.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where GROV advanced for three days, in 147 of 191 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 48 cases where GROV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.

GROV broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GROV entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.655) is normal, around the industry mean (21.731). P/E Ratio (-5.450) is within average values for comparable stocks, (16.288). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.518). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (0.254) is also within normal values, averaging (1.902).

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. GROV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GROV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 25.17B. The market cap for tickers in the group ranges from 60.48K to 384.17B. PG holds the highest valuation in this group at 384.17B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was 10%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 26%. SKIN experienced the highest price growth at 62%, while FRTT experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was -3%. For the same stocks of the Industry, the average monthly volume growth was 110% and the average quarterly volume growth was 40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 49
Price Growth Rating: 49
SMR Rating: 73
Profit Risk Rating: 86
Seasonality Score: 27 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry HouseholdPersonalCare

Industry
N/A
Address
1301 Sansome Street
Phone
+1 800 231-8527
Employees
295
Web
https://www.grove.co
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
CCAP climbed +7.03% during regular market hours, rising from a prior close of $9.24 to $9.89. The rally followed its Q3 2026 report: net investment income of $0.37/share beat the $0.35 consensus and revenue of $36.9M topped estimates, alongside a new $50M buyback authorization plus up to $25M in additional Sun Life purchases.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.